Loading...

OBIO ORCHESTRA BIOMED HOLDINGS INC Company Mergers 8-K Filing

RCHS

B

ORCHESTRA BIOMED HOLDINGS INC

(OBIO)

2026 8-K

Executive Compensation Update

Acquisition Proceeds

Business Update Call

Investor Presentation Update

Termination Agreement

Equity Offerings

Regulatory Compliance

Investigational Device Exem...

Investor Presentation

Executive Compensation Changes

Sales Agreement

Appointment of Director

Annual Meeting Voting Results

Regulation FD Disclosure

Annual Meeting of Stockholders

Agreement Amendment

Regulation FD Disclosure

Registration Statement and ...

FDA Approval for BackBeat C...

Departure of Chief Financia...

Disclosure of Slide Present...

Regulation FD Disclosure

Merger Completed

Meeting Approval

Delisting Notice

General Meeting

External Links:

On January 12, 2026, Orchestra BioMed Holdings, Inc. announced it will receive up to $21 million from the acquisition of Vivasure by Haemonetics.

AI Assistant

ORCHESTRA BIOMED HOLDINGS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.